NCT06828991
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06828991
Title A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP (GOLD)
Acronym GOLD
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Danielle Wallace
Indications
Therapies
Age Groups: senior
Covered Countries USA


No variant requirements are available.